Ten years of Descemet membrane endothelial keratoplasty: Identifying risk factors and early failure signs

dc.contributor.authorMechleb, Nicoleen_US
dc.contributor.authorRizk, Mariaen_US
dc.contributor.authorDebellemanière, Guillaumeen_US
dc.contributor.authorGatinel, Damienen_US
dc.contributor.authorSaad, Alainen_US
dc.date.accessioned2025-08-13T11:27:45Z
dc.date.available2025-08-13T11:27:45Z
dc.date.issued2025-07
dc.description.abstractPurpose: To evaluate the effect of surgical indications and complexity on long?term clinical outcomes in Descemet membrane endothelial keratoplasty (DMEK) and identify early signs of graft failure. Design: Retrospective case series of 105 patients who underwent DMEK from March 2012 to December 2014. Methods: Surgical results were analyzed at 1 year, 3 years, 5 years, and 10 years based on surgical indication: fuchs endothelial dystrophy (FECD) (n = 47) and bullous keratopathy (BK) (n = 58), and on the presence of anterior segment comorbidities: simple (n = 63) versus complex (n = 42) DMEK. Results: Fifty?two patients (54 eyes) were followed up for 3 years, 35 patients (42 eyes) reached the 5?year follow?up, and 20 patients (26 eyes) achieved the 10?year follow?up. Simple DMEK procedures and FECD demonstrated significantly better best corrected visual acuity (BCVA) compared to complex DMEK and BK at 1 year, 3 years, 5 years, and 10 years, respectively (P < 0.01). No statistically significant difference in endothelial cell density (ECD) decline was noted between simple and complex DMEK procedures, nor between FECD and BK (P > 0.05). Central and peripheral pachymetry were significantly higher in BK and complex surgeries at 10 years. Conclusion: While DMEK represents a promising therapeutic avenue for corneal decompensation alongside anterior segment comorbidities, extended follow?up indicates a rise in central and peripheral pachymetry in comparison with simple DMEK. This increase could serve as an early indicators of corneal decompensation, potentially leading to reduced survival rates.en_US
dc.identifier.affiliationsDepartment of Ophthalmology, Rothschild Foundation Hospital, Paris, France; CEROV: Center of Expertise and Research in Visual Optics, Paris, Franceen_US
dc.identifier.affiliationsDepartment of Ophthalmology, Rothschild Foundation Hospital, Paris, France; CEROV: Center of Expertise and Research in Visual Optics, Paris, Franceen_US
dc.identifier.affiliationsDepartment of Ophthalmology, Rothschild Foundation Hospital, Paris, France; CEROV: Center of Expertise and Research in Visual Optics, Paris, Franceen_US
dc.identifier.affiliationsDepartment of Ophthalmology, Rothschild Foundation Hospital, Paris, France; CEROV: Center of Expertise and Research in Visual Optics, Paris, Franceen_US
dc.identifier.affiliationsDepartment of Ophthalmology, Rothschild Foundation Hospital, Paris, France; CEROV: Center of Expertise and Research in Visual Optics, Paris, Franceen_US
dc.identifier.citationMechleb Nicole, Rizk Maria, Debellemanière Guillaume, Gatinel Damien, Saad Alain. Ten years of Descemet membrane endothelial keratoplasty: Identifying risk factors and early failure signs. Indian Journal of Ophthalmology. 2025 Jul; 73(7): 1021-1026en_US
dc.identifier.issn0301-4738
dc.identifier.issn1998-3689
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/253880
dc.languageenen_US
dc.publisherWolters Kluwer – Medknowen_US
dc.relation.issuenumber7en_US
dc.relation.volume73en_US
dc.source.urihttps://doi.org/10.4103/IJO.IJO_2273_24en_US
dc.subjectBullous keratopathyen_US
dc.subjectdescemet membrane endothelial keratoplasty (DMEK)en_US
dc.subjectendothelial dysfunctionen_US
dc.subjectkeywords fuchs’ endothelial corneal dystrophyen_US
dc.titleTen years of Descemet membrane endothelial keratoplasty: Identifying risk factors and early failure signsen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ijo2025v73n7p1021.pdf
Size:
1.1 MB
Format:
Adobe Portable Document Format